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Scientific Knowledge on the Subject: Glucocorticoid unresponsiveness in severe asthma 
COPD may involve an oxidant mediated impairment of glucocorticoid receptor alpha (GRα) 
function through reduction of histone deacetylase activity and co-repressor expression.  
What This Study Adds to the Field: Histone deacetylase 2 activity is reduced in smoke 
exposed mice lungs correlating with reduced glucocorticoid function which is restored by 
PI3Kδ but not γ inhibition. GRα expression also is reduced in smoke exposed mouse and in 
COPD patient lungs. 
Abstract 
Rational: There is an increasing prevalence of reduced responsiveness to glucocorticoid 
therapy in severe asthma and chronic obstructive pulmonary disease, however the molecular 
mechanism of this remains unknown. Recent studies have shown that histone deacetylase 
activity, which is critical to glucocorticoid function, is altered by oxidant stress and may be 
involved in the development of glucocorticoid insensitivity.  
Objectives: To determine the role of phosphoinositol-3-kinase (PI3K) in the development of 
cigarette smoke induced glucocorticoid insensitivity.  
Methods: Wild type, PI3Kγ knock-out and PI3Kδ kinase dead knock-in transgenic mice were 
used in a model of cigarette smoke induced glucocorticoid insensitivity. Peripheral lung tissue 
was obtained 6 healthy non-smokers, 9 smokers with normal lung function and 8 patients with 
chronic obstructive pulmonary disease. 
Measurements and Main Results: Glucocorticoid receptor expression was significantly 
reduced in both the lungs of chronic obstructive pulmonary disease patients and in cigarette 
smoke-exposed mice. Furthermore, cigarette smoke exposure in mice increased tyrosine 
nitration of histone deacetylase 2 in the lung correlating with both reduced histone 
deacetylase 2 activity and reduced glucocorticoid function. Oxidative stress activated Akt and 
induced glucocorticoid insensitivity in vitro, which was restored by inhibition of PI3K. In 
vivo, histone deacetylase 2 activity and the anti-inflammatory effects of glucocorticoids were 
restored in PI3Kδ kinase dead knock-in but not PI3Kγ knock-out smoke exposed mice 
compared to wild types, correlating with reduced histone deacetylase 2 tyrosine nitration. 
Conclusion: Together these data shows that therapeutic inhibition of PI3Kδ may restore 
glucocorticoid function in oxidative stress induced glucocorticoid insensitivity.  
Abstract Word count: 247 
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Introduction 
Glucocorticoids are ineffective in severe asthma and chronic obstructive pulmonary disease 
(COPD), even at high oral doses thereby presenting considerable disease management 
problems and cost burden with few effective alternative treatments (1;2). Both these 
conditions have a strong component of oxidative stress which may contribute to the 
development of this apparent glucocorticoid unresponsiveness, however, the precise 
molecular mechanism(s) of this apparent impairment remains unclear.  
The human GR gene encodes two isoforms; GRα, through which the actions of 
glucocorticoids are mediated, and the non glucocorticoid binding GRβ (3). The major 
glucocorticoid anti-inflammatory action is mediated by transrepression of pro-inflammatory 
genes (4). Here, GRα monomers associate with promoter bound transcription factors such as 
nuclear factor NF-κB and AP-1 (5) followed by  recruitment ‘co-repressor complexes’ such as 
mSin3a (mammalian Sin3a) and Mi-2α/β (chromodomain helicase DNA binding protein) (6-
8). These act as ‘scaffold proteins’ by assembling multiple components including histone 
deacetylase (HDAC) activity, and critically HDAC-2 (9;10), which is recruited to remove the 
acetyl moieties from the amino terminal (NH) tails of the core histones at the promoter sight 
of transcriptional active genes. This allows ‘re-condensation’ of the DNA around the core 
histone proteins, thereby dislodging the transcriptional machinery leading to cessation of gene 
transcription (11). HDAC-2 is also implicated in deacetylation of other transcriptional 
regulators including GRα itself, thereby allowing NF-κB binding and subsequent 
glucocorticoid-mediated transrepression of NF-κB dependant gene expression (10). Indeed, in 
relative glucocorticoid insensitive conditions including severe asthma and COPD, HDAC-2 
expression is reduced, correlating with increased pro-inflammatory cytokine release, relative 
glucocorticoid insensitivity and disease severity (12-14). Furthermore, knock-down of 
HDAC-2 expression in bronchoalveolar (BAL) macrophages induces a relative glucocorticoid 
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insensitivity and conversely overexpression of HDAC-2 in BAL macrophages from patients 
with COPD restores glucocorticoid function (10). 
The bronchodilator theophylline acts as a glucocorticoid sparing agent in asthmatics (15) and 
has can restore glucocorticoid function in alveolar macrophages from COPD patients in vitro, 
corresponding with restored HDAC-2 activity (16;17), however the mechanism remains 
unclear. One of the potential targets of theophylline is the lipid kinase phosphoinositol-3-
kinase (PI3K) (18). Furthermore, both PI3Kδ and γ are proposed as potential anti-
inflammatory targets (19;20) with PI3Kδ implicated in B- and T- cell signalling, mast cell 
mediated allergic response and neutrophil activation and PI3Kγ linked to neutrophil 
activation, mast cell degranulation and T cell function (21-24). 
Here we investigate the molecular mechanism of glucocortioid insensitivity. Using transgenic 
mice in an animal model of cigarette smoke-induced glucocorticoid resistance we show a 
reduction in HDAC-2 activity correlating with reduced glucocorticoid function which is 
restored by PI3Kδ but not γ inhibition with further alterations in lung mSin3a and Mi-2α/β 
expression and a reduction in lung GRα expression. Furthermore, both GRα and GRβ 
expression is reduced in COPD patient lungs. 
 
Methods 
Cell culture & Treatments. U937 cells were cultured in RPMI 1640 GlutaMAX media with 
10% and BEAS-2B cells were cultured in Keratinocyte media with LG and supplements for 
K-SFM. All cell culture reagents were purchased from Invitrogen (Paisley, UK), unless 
otherwise stated. Reagents: H2O2 (Sigma Dorset, UK), LY294002 (Merck Biosciences, 
Nottingham, UK), busesonide (Sigma) and TNFα (R&D Systems, Abingdon, UK). 
Antibodies: Akt (New England BioLabs, Herts, UK); HDAC-2, GRα, lamin A/C, actin (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA); mSin3a, GAPDH, Nitrotyrosine and 
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phosphoserine (Abcam, Cambridge, UK); GRβ (Affinity Bioreagents, CO, USA); Mi-2α/β 
(Austral Biologicals, San Ramon, CA, USA). 
 
Cigarette smoke induced GC insensitive mouse model: Studies described herein were 
performed under a Project License issued by the United Kingdom Home Office and protocols 
were approved by the Local Ethical Review Process. Both PI3Kγ-/- and  PI3KδD910A/D910A 
mice have been described previously (25;26). Mice were exposed to either cigarette smoke 
(5x1R3F cigarettes/day) or room-air on 3 consecutive days as previously described (27) and 
dosed with either budesonide (1mg/kg) or vehicle (saline with 2% NMP) by intranasal (i.n.) 
administration one hour prior to exposure. Animals were sacrificed 24 hours with bronchiolar 
lavage and differential cell counts performed as previously described (27).  
 
Protein extraction, Immunoblotting and Immunoprecipitation. Cytosolic proteins were 
extracted using a hypotonic lysis buffer (10mM Tris HCl pH6.5, 0.5mM Na Bisulfite, 10mM 
MgCl2, 8.6% sucrose, 0.5% NP-40 phosphatase inhibitors and protease inhibitors). Nuclear 
proteins were extracted using a high salt extraction buffer (15mM Tris HCL pH 7.9, 450mM 
NaCl, 10% glycerol, phosphatase inhibitors and protease inhibitors) and nuclear extract salt 
concentrations normalised with 2 volumes of a Tris-glycerol buffer (15mM Tris HCL pH 7.9, 
10% glycerol, phosphatase inhibitors and protease inhibitors). Protein quantification was 
assessed by BCA assay (Perbio, Northumberland, UK). Immunoblotting and 
immunoprecipitation was performed as previously described (28).  
 
ELISA & HDAC activity assay. KC and IL-6 and IL-8 levels were measured using 
Quantikine ELISA kits (RnD Systems), and HDAC activity was measure by HDAC activity 
assay kit (Biomol International, PA, USA) according to manufacturer’s instructions. 
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 Human study subjects. All subjects were recruited from the Section of Respiratory 
Medicine of the University Hospital of Ferrara, Italy with approval by the local ethics 
committee of the University Hospital of Ferrara (table 1). All the subjects were free from 
bronchodilator, theophylline, antibiotic, antioxidant and/or glucocorticoid therapy in the last 
month before surgery. Pulmonary function tests were performed as previously described (29). 
COPD and chronic bronchitis were respectively defined, according to international 
guidelines, as the presence of post-bronchodilator FEV1/FVC ratio<70% or the presence of 
cough and sputum production for at least 3 months in each of two consecutive years (30). 
Lung tissue processing and immunohistochemistry was performed as previously described 
(29).  
 
Statistical analysis. For all experiments, the statistical significance of differences between 
samples was calculated on GraphPad Prism software using Students t-test (Mann-Whitney 
test). Data is expressed as mean ± SEM, differences were considered significant if P < 0.05. 
 
Results 
Oxidative stress induces Akt phosphorylation and reduced glucocorticoid function in 
vitro. Hydrogen peroxide (H2O2) induced Akt phosphorylation in a time and PI3K-dependant 
manner (Fig. 1A). H2O2 exposure alone only induced a small 0.5-1 fold increase in IL-8 
release, but augmented the levels of IL-8 release induced by TNFα (Fig. 1B). Pre-treatment 
with 100nM dexamethasone gave a maximal inhibition of TNFα mediated IL-8 release (~50-
60%), however in cells exposed to H2O2, 100nM dexamethasone was only able to reduced 
TNFα induced IL-8 levels to that comparable to TNFα alone (Fig. 1B). Inhibition of PI3K 
restored dexamethasone suppression of IL-8 release with no apparent impact alone (Fig. 1C). 
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 Inhibition of PI3Kδ enables glucocorticoid suppression of cigarette smoke-induced lung 
inflammation. BAL neutrophil counts (Fig. 2) and whole lung tissue levels of the pro-
inflammatory cytokines keratinocyte-derived chemokine (KC) and IL-6 (Fig. 3A, B) were 
measured as markers of cigarette smoke induced lung inflammation. Cigarette smoke 
exposure induced a marked inflammatory response in WT mice which budesonide failed to 
reduce, confirming this as a model of glucocorticoid insensitivity. There were no significant 
differences in either neutrophil number (Fig. 2) or cytokine lung tissue levels (Fig. 3A, B) 
between the wild type BALB/c (WT) and PI3Kδ kinase dead knock-in PI3KδD910A/D910A or PI-
3Kγ knockout PI3Kγ-/- sham exposed mice. Cigarette smoke exposure resulted in both an 
influx of neutrophils into the lung and increased KC and IL-6 lung tissue levels. Budesonide 
treatment at 1mg/kg failed to reduce either the neutrophil influx or tissue cytokine levels in 
the WT mice, confirming glucocorticoid insensitivity in this model (Fig. 3A, B). However, 
budesonide treatment in PI3KδD910A/D910A mice, but not PI3Kγ-/- reduced both the neutrophil 
influx and lung tissue cytokine levels, indicating that the PI3Kδ pathway may play a role in 
the development of cigarette smoke induced glucocorticoid insensitivity. 
 
Inhibition of PI3Kδ restores HDAC activity after cigarette smoke exposure in vivo. 
Oxidative stress can impair HDAC-2 activity which is implicated in the development of 
glucocorticoid insensitivity. Consistent with this, total nuclear HDAC and nuclear HDAC-2 
activity was reduced in WT and PI3Kγ-/- mice lungs (Fig. 4 A, B). However, in smoke 
exposed PI3KδD910A/D910A mice, both total nuclear and nuclear HDAC-2 activity was 
unaffected (Fig. 4A, B). Budesonide treatment had no significant effect on either total nuclear 
HDAC or HDAC-2 activity. There was no difference in nuclear HDAC-2 expression levels 
between any of the groups (data not shown) indicating that the observed reduction in HDAC-
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2 activity was due to reduced activity alone rather than a reduction in expression. To establish 
the cause of the reduced HDAC-2 activity, expression levels and post-translational 
modifications were assessed (Fig. 5). Assessment of immunoprecipitated HDAC-2 revealed 
that both tyrosine nitration and serine phosphorylation were elevated in the smoke exposed 
WT mice with no impact of PI3Kγ-/- (Fig. 5A, B). However, both tyrosine nitration and serine 
phosphorylation of HDAC-2 were reduced in smoke exposed PI3KδD910A/D910A mice compared 
to WT controls (Fig. 5 A, B). Budesonide treatment had no additional impact on either 
tyrosine nitration of serine phosphorylation in any group.  
 
Cigarette smoke exposure alters mSin3a and Mi-2α/β expression. It is possible that the 
cigarette smoke-induced reduction in HDAC-2 activity may relate to changes in the 
expression of other co-repressor components such as the ‘chaperone proteins’ mSin3a and 
Mi-2α/β which co-ordinate and orchestrate the HDAC-2 co-repressor complex. Both mSin3a 
and Mi-2α expression was reduced in cigarette smoke exposed mice with no impact of either 
PI3K δ or γ inhibition (Fig. 6A, B). Interestingly, budesonide treatment prevented the 
reduction of mSin3a expression in all groups (Fig. 6A), however Mi-2α expression was only 
maintained in the budesonide treated PI3Kγ-/-, PI3KδD910A/D910A mice (Fig. 6B). Conversely, 
Mi-2β expression was elevated in all smoke exposed groups with no discernable difference 
between PI3Kδ or γ inhibition or any further impact by budesonide treatment (Fig. 6C).  
 
GR expression is reduced by cigarette smoke and in COPD peripheral lung tissue. The 
reduction in glucocorticoid function in the smoke exposed mice may also be due to an 
alteration in the expression and/or translocation of GRα itself. There was no difference in 
GRα protein expression between WT and PI3Kγ-/-or PI3Kδ D910A/D910A sham mice in either the 
cytosolic or nuclear compartments. Cigarette smoke exposure significantly reduced GRα 
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protein expression with no impact of either PI3Kδ or γ inhibition (Fig. 7 A, B). However, 
there was also no difference in the GRα cytosolic:nuclear ratios in the smoke exposed mice 
with and without budesonide treatment (data not shown) indicating that budesonide mediated 
GRα translocation is ineffective in smoke exposed animals. To assess if this reduction in 
GRα expression was translated in humans in an oxidant driven glucocorticoid insensitive 
disease, peripheral lung from COPD patients, age matched normal subjects and smokers with 
normal lung function was assessed (Table 1). Immunohistochemical analysis demonstrated 
GRα staining of the bronchiolar and alveolar epithelial cells, bronchiolar smooth muscle cells, 
endothelial cells and infiltrating cells with no significant difference between nuclear and 
cytosolic localisation seen between COPD patients and the control groups (Fig. 8A-F). There 
was a significant reduction in the expression of both GRα and GRβ protein in the peripheral 
lung of COPD patients compared to age-matched normal subjects and smokers with normal 
lung function (Fig. 8G, H). 
 
Discussion 
We show here that oxidative stress results in loss of glucocorticoid function associated with 
increased post-translational modifications of HDAC-2 and subsequent reduction in HDAC-2 
activity. Specific inhibition of PI3Kδ protected/restored HDAC activity correlating with 
attenuation of post-translational modifications and restored glucocorticoid function. 
Furthermore, we show that oxidative stress impacts on the GR/HDAC-2 co-complex- 
repressors mSin3a and Mi-2α/β. Although oxidative stress reduced GRα expression, 
restoration of GRα function in PI3KδD910/D910 mice does not alter GR expression. 
Oxidative stress impaired glucocorticoid anti-inflammatory action and elevated Akt 
phosphorylation in a time and PI3K-dependant manner. Further preliminary data showed 
elevated Akt phosphorylation in peripheral blood mononuclear cells from patients with COPD 
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compared with normal age-matched non-smokers (2.00±0.57 versus 1.14±0.21, data not 
shown). Interestingly, LY294002 restored glucocorticoid function in oxidative stressed cells 
whilst having no anti-inflammatory effect on its own. Indeed, cigarette smoke exposure 
induced a similar inflammatory response in the lungs of both PI3Kγ-/- and PI3KδD910A/D910A 
mice indicating that acutely, neither of these isoforms impact on oxidant induced 
inflammation. Contrary to this, both pharmacological and knock out studies show that  PI3Kγ 
and δ inhibition is in itself anti-inflammatory (20-24;31-33). However, recent evidence 
suggests that an anti-inflammatory action in response to cigarette smoke may take weeks to 
develop, thus the 3 days of smoke exposure may not have been sufficient for any anti-
inflammatory effect of PI3Kγ-/- or PI3KδD910A/D910A to be seen (34). Interestingly, budesonide 
pre-treatment had no impact on the inflammatory response in PI3Kγ-/- mice, but reduced the 
inflammatory response in PI3KδD910A/D910A mice indicating that oxidative induced 
glucocorticoid insensitivity may be linked to activation of PI3Kδ specific signalling. However 
the specific signalling pathways of the PI3Kδ isoforms remain unclear.  
Smoke exposure also reduced both cytoplasmic and nuclear GR expression in the lung tissue 
with no apparent impact of PI3K inhibition. Interestingly, there was also no significant 
elevation of GRα levels in the nuclear compartment with budesonide, indicating that cigarette 
smoke exposure may impact on GRα translocation. However, as glucocorticoid function was 
restored in PI3KδD910A/D910A mice with no further impact on GRα expression or translocation, 
the endogenous levels of nuclear GRα may have been sufficient to provide relative restoration 
of the anti-inflammatory transrepression without elevated GRα translocation. This data 
therefore suggests that the reduction of GRα is unlikely to be the primary mechanism of 
glucocorticoid insensitivity in this model. Consistent with this model of cigarette smoke 
induced glucocorticoid insensitivity, assessment in clinical tissues revealed that GRα 
 9
expression is reduced in the periphery of the lung of smokers and is further reduce in the 
lungs from patients with the glucocorticoid-insensitive disease COPD. Furthermore, lung 
GRβ expression was also reduced in both smokers and COPD, indicating that GRβ is unlikely 
to play a significant role in the development of glucocorticoid insensitivity in COPD.   
HDAC-2 activity is critical to GRα transrepression and impaired HDAC-2 activity may be 
central in both glucocorticoid insensitivity in both severe asthma and COPD (10;12;13). 
Consistent with this, both total nuclear HDAC and nuclear HDAC-2 activity in the lung was 
reduced in smoke exposed mice. Interestingly however, inhibition of PI3Kδ but not PI3Kγ 
protected nuclear total HDAC and HDAC-2 activity, correlating with the glucocorticoid 
insensitivity in smoke exposed wt and PI3Kγ-/- but not PI3KδD910A/D910A mice. HDAC-2 
expression itself remained unchanged in all groups indicating that reduction of activity must 
be post translational rather than an effect on expression per se. We have previously shown 
that HDAC-2 is subject to oxidative modifications which may in turn alter its activity and 
hyperphosphorylation is known to disrupt HDAC-2 interactions with other co-repressors 
(28;35;36). Indeed, both HDAC-2 tyrosine nitration and serine phosphorylation were elevated 
in smoke exposed animals and again, consistent with both the HDAC-2 activity and 
glucocorticoid function, only the PI3KδD910A/D910A mice had reductions in both tyrosine 
nitration and phosphorylation. This correlation between HDAC-2 activity, modifications and 
glucocorticoid function with PI3K inhibition may therefore provide a potential mechanism 
and therapeutic target for the restoration of glucocorticoid function. 
Relatively little is known about either the composition or the stepwise construction/targeting 
of the GRα/HDAC-2 co-repressor complexes. The co-repressor ‘scaffold’ proteins mSin3a 
and Mi-2α/β are through to coordinate the construction of the co-repressor complexes to 
deliver both HDAC and methyl transferease activity to the site of gene transcription (6-8). It 
is highly likely that oxidant stress induced alterations in these other co-repressor components, 
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potentially contributing to the mechanism of oxidative induced glucocorticoid insensitivity. 
Indeed, smoke exposure reduced both mSin3a and Mi-2α expression in the lung whilst Mi-2β 
was conversely elevated. Interestingly, glucocorticoid treatment elevated mSin3a expression 
independent of PI3Kγ/δ inhibition, whilst only restoring Mi-2α expression in mice with PI-
3Kγ/δ inhibition. To our knowledge this is the first time that the direct impact oxidative stress 
on the expression of either mSin3a or Mi-2α/β has been studied and these alterations may 
further contribute to the mechanism of cigarette smoke mediated glucocorticoid insensitivity. 
Further investigation is needed to elucidate any functional and direct/indirect impact these and 
other changes in the co-repressor complexes induced by cigarette smoke have on oxidant 
induced corticosteroid insensitivity.  
Although cigarette smoke exposure in animal models is often used to induce structural 
changes in the lung representative of emphysema-like pathology, the desired relative 
glucocorticoid-insensitivity for this study was achieved after a relatively acute exposure. 
Therefore no projection can be made as to the possible impact of PI3K isoform inhibition on 
structural changes induced by cigarette smoke and which are beyond the remit of this study. 
Combined this data shows that oxidative stress confers a relative glucocorticoid insensitivity 
in the airways during cigarette smoke-induced inflammation which is protected by specific 
inhibition of the PI3Kδ by a mechanism that involves the restoration of HDAC-2 activity. 
Furthermore, oxidant induced reduction of GRα expression, impaired translocation and 
alteration in mSin3a and M2α may limiting the level of nuclear GRα available for 
transrepression, thereby representing represent additional mechanisms by which oxidative 
stress impairs glucocorticoid sensitivity. Clinically, the development of PI3Kδ specific 
inhibitors may provide a means of overcoming the relative glucocorticoid insensitivity 
induced by oxidative stress in conditions such as COPD and severe asthma that affect millions 
of patients worldwide and whose current therapy is sub-optimal.  
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 Table 1: Characteristics of subjects for the study 
Subjects 
 
n Age Sex Smoking 
history 
Pack-
years 
Chronic 
bronchitis
FEV1*
% pred 
FEV1/ 
FVC†% 
NS‡ 6 70.0±.3.0 4M
§,/2F** None 0 None 102.2±5.6 77.7±3.1
Smoker 9 67.3±2.6 8M/1F 5 Ex†† : 4 Cur‡‡ 30.1±5.5 6 yes : 3 no 95.9±6.1 76.0±1.3
COPD 8 70.0±1.6 8M 4 Ex : 4 Cur  39±5.2 6 yes : 2 no 85.3±3.7 66.5±1.0
For COPD and smokers with normal lung function subjects FEV1 %predicted and FEV1/FVC% are post-
bronchodilator values; data expressed as mean ± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
* Forced expiratory volume in one second 
† Forced vital capacity 
‡ Non-Smoker 
§ Male 
** Female 
†† Ex-smoker 
‡‡ Current smoker 
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Figure 1. Impact of oxidative stress on PI3K phosphorylation and glucocorticoid function in vitro. (A) 
Blocked induction of 200μM H202 Akt phosphorylation by 1μM LY294002. (B) 200μM H202 mediated 
reduction in dexamethasone inhibition of TNFα induced IL-8 release. (C) Restoration of 
dexamethasones inhibition of TNFα induced IL-8 release by 1μM LY294002. Abbreviations; LY: 
LY294002; Dex: Dexamethasone. 
 
Figure 2. PI3KδD910A/D910A but not PI3Kγ-/- restored budesonide mediated suppression of lung 
neutrophil recruitment in smoke exposed mice. All data represents the mean ± S.E.M (n=7-8). 
Abbreviations; S: Smoke Exposed; Bud: Budesonide. 
 
Figure 3. Inflammatory cytokine profile of smoke exposed mouse lung; impact of PI3Kγ-/- and 
PI3KδD910A/D910A. (A) Restored budesonide mediated reduction in lung tissue KC levels in 
PI3KδD910A/D910A but not PI3Kγ-/- smoke exposed mice. (B) Restored budesonide mediated reduction in 
lung tissue IL-6 levels in PI3KδD910A/D910A but not PI3Kγ-/- smoke exposed mice. All data represents the 
mean ± S.E.M (n=7-8). Abbreviations; S: Smoke Exposed; Bud: Budesonide. 
 
Figure 4. HDAC-2 activity in smoke exposed mouse lung; impact of PI3Kγ-/- and PI3KδD910A/D910A. (A) 
Restored total nuclear HDAC activity in PI3KδD910A/D910A but not PI3Kγ-/- smoke exposed mice lungs. 
(B) Restored nuclear HDAC-2 activity in PI3KδD910A/D910A but not PI3Kγ-/- smoke exposed mice lungs. 
All data represents the mean ± S.E.M (n=7-8). Abbreviations; S: Smoke Exposed; Bud: Budesonide. 
 
Figure 5. HDAC-2 posttranslational modifications in smoke exposed mouse lung; impact of PI3Kγ-/- 
and PI3KδD910A/D910A. (A) Reduced nuclear HDAC-2 tyrosine nitration in PI3KδD910A/D910A but not PI3Kγ-/- 
smoke exposed mice lungs. (B) Reduced nuclear HDAC-2 serine phosphorylation in PI3KδD910A/D910A 
but not PI3Kγ-/- smoke exposed mice lungs. Immunoblot is a representative image from n=7-8. 
Histograms represent the mean ± S.E.M (n=7-8). Abbreviations; S: Smoke Exposed; Bud: 
Budesonide; N-Tyr: Tyrosine Nitration; P-Ser: Serine Phosphorylation. 
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Figure 6. Expression of co-repressor complex proteins mSin3a and Mi-2 in smoke exposed mouse 
lung; impact of PI3Kγ-/- and PI3KδD910A/D910A. (A) Reduced nuclear mSin3a expression in smoke 
exposed mice lungs with no impact of either PI3Kγ-/- or PI3KδD910A/D910A. (B) Restored Mi-2α expression 
in both PI3Kγ-/- and PI3KδD910A/D910A smoke exposed mice lungs. (C) Elevated Mi-2β expression in 
smoke exposed mice lungs with no impact of either PI3Kγ-/- or PI3KδD910A/D910A. Immunoblot is a 
representative image from n=7-8. Histograms represent the mean ± S.E.M (n=7-8). Abbreviations; S: 
Smoke Exposed; Bud: Budesonide. 
 
Figure 7. GRα expression in smoke exposed mouse lung; impact of PI3Kγ-/- and PI3KδD910A/D910A. (A) 
Reduced cytosolic GRα expression in smoke exposed mice lungs with no impact of either PI3Kγ-/- or 
PI3KδD910A/D910A. (B) Reduced nuclear GRα expression in smoke exposed mice lungs with no impact of 
either PI3Kγ-/-, PI3KδD910A/D910A or budesonide treatment. Immunoblot is a representative image from 
n=7-8. Histograms represent the mean ± S.E.M (n=7-8). Abbreviations; S: Smoke Exposed; Bud: 
Budesonide. 
 
Figure 8. GR expression in the peripheral lung parenchyma of COPD lungs versus non-smoked and 
smokers. (A-F) GRα staining of the bronchiolar and alveolar epithelial cells, bronchiolar smooth 
muscle cells, endothelial cells and infiltrating cells. (G) Expression of GRα protein in peripheral lung of 
COPD patients (n=8) and smokers with normal lung function (n=9) compared to age-matched normal 
subjects (n=6). (H) Expression of GRβ protein in peripheral lung of COPD patients (n=8) and smokers 
with normal lung function (n=9) compared to age-matched normal subjects (n=6). 
Immunohistochemical and immunoblot pictures are representative images from n=6-9. Histograms 
represent the mean ± S.E.M (n=6-9). 
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